Glaxosmithkline Share News (GSK)

UPDATE 1-Novartis says 3 executives to leave after GSK, Lilly deals

(Adds details, background) ZURICH, Oct 8 (Reuters) - Swiss drugmaker Novartis AG said three members of its executive committee would leave the company following the completion of transactions with GlaxoSmithKline and Eli Lilly to divest three units. Novartis agreed on a series of dea

DIRECTOR DEALINGS: GlaxoSmithKline Executive, Directors Acquire Shares

London midday: Mining gains offset by falls from airline, healthcare stocks

Poor economic data was weighing on UK stocks on Tuesday, with decent gains in the mining sector offset by falls from airlines and pharmaceuticals. The FTSE 100 was trading 0.6% lower at 6,522 by around midday. Nervousness ahead of the start of third-quarter earnings season in the States was also ca

UK WINNERS & LOSERS: Travel, Leisure Sector Hit By Spain Ebola Case

Glaxo's Stiefel Starts Phase III Study Of Subcutaneous Ofatumumab

Tuesday broker round-up UPDATE

African Minerals: Canaccord Genuity lowers target price from 20p to 15p with a hold recommendation. Aggreko: Exane initiates with a target price of 1500p and an underperform rating. Amec: Liberum Capital cuts target price from 1035p to 908p staying with its sell recommendation. Antofagasta: Canacc

UK BROKER RATINGS: Merrill Lynch Cuts Schroders To Underperform

London open: UK stocks drop despite mining gains

Strong gains in the UK mining sector weren't enough to keep London's FTSE 100 from slipping into the red on Tuesday morning. Indices across Europe were tracking a weak finish on Wall Street and a mixed performance on Asian markets overnight. The FTSE 100 was trading 0.6% lower at 6,526 within the o

Sanofi says told U.S. about bribery claims in Africa, Mideast

PARIS, Oct 7 (Reuters) - French drugmaker Sanofi said it had informed U.S. authorities of allegations of improper payments by its employees to healthcare professionals in East Africa and the Middle East, in the latest of a string of bribery claims embarrassing the pharmaceutical industry.

DIRECTOR DEALINGS: Glaxo Executives Reinvest Dividends

RPT-Aid workers ask where was WHO in Ebola outbreak?

(Repeats story from Sunday without changes) * Calls for reform of U.N. health agency after mishandling Ebola * Hit by cuts, WHO rebuffed calls to play more active role * Crisis was complicated by weak governments, cultural factors * MSF coordinator says agency displayed sh

Aid workers ask where was WHO in Ebola outbreak?

* Calls for reform of U.N. health agency after mishandling Ebola * Hit by cuts, WHO rebuffed calls to play more active role * Crisis was complicated by weak governments, cultural factors * MSF coordinator says agency displayed shocking amateurism * Calls for larger WHO bud

DIRECTOR DEALINGS: Glaxo Executives Reinvest Dividends

UPDATE 1-EU Commission clears Eli Lilly, Novartis deal

(Adds details of deal) BRUSSELS, Oct 3 (Reuters) - EU antitrust regulators approved U.S. drugmaker Eli Lilly's $5.4 billion takeover of Swiss peer Novartis's animal health business on Friday. The European Commission said it was satisfied that the deal would not hinder competition and

UK Dividends Calendar - Week Ahead